The Efficacy of Intravitreal Conbercept for Chronic Central Serous Chorioretinopathy.
Jianbo MaoCaiyun ZhangChenyi LiuLijun ShenJimeng LaoYirun ShaoYiqi ChenJiwei TaoPublished in: Journal of ophthalmology (2019)
Intravitreal injection of conbercept may effectively reduce the CMT and improve the BCVA in chronic CSC in a short term of 6 months.